Site Search

1. 341.
   AMP/assets/File/clinical-practice/1025_32-34_AMPcase-Sabath_HiRes.pdf?pass=65

   Updated March 7, 2023. https://www.ncbi.nlm.nih.gov/books/NBK470433/3. Kuo AJ, Paulson VA, Hempelmann JA, et al. Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. Pract Lab Med. 2020;19:e00153. 4. Woyach JA, Ruppert AS, Guinn D, et al. BTKC481S-mediated resistance to

   https://www.amp.org/AMP/assets/File/clinical-practice/1025_32-34_AMPcase-Sabath_...
2. 342.
   AMP/assets/File/advocacy/AMP-Response-NASEM-Forum-PHE-Preparedness.pdf?pass=16

   Should you have any questions or wish to discuss these issues further, please don’t hesitate to contact Sarah Thibault-Sennett at SThibaultSennett@amp.org. Sincerely, Daniel E. Sabath, MD PhD President, Association for Molecular Pathology 1 https://www.amp.org/advocacy/sars-cov-2-survey

   https://www.amp.org/AMP/assets/File/advocacy/AMP-Response-NASEM-Forum-PHE-Prepar...
3. 343.
   AMP/assets/File/pressreleases/2023/Press_Release_AMP_Multiplex_ID_Guideline.pdf...

   To read the full manuscript, please visit https://doi.org/10.1016/j.jmoldx.2023.08.005. ABOUT AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 2,900+ members practice various disciplines of molecular diagnostics, including bioinformatics,

   https://www.amp.org/AMP/assets/File/pressreleases/2023/Press_Release_AMP_Multipl...
4. 344.
   AMP/assets/File/pressreleases/2021/AMP_MDx_Interpretation_Assessment.pdf?pass=75

   Test Interpretation, please visit: https://www.amp.org/MDx_Survey_Report. ABOUT AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice various disciplines of molecular diagnostics, including bioinformatics, infectious diseases,

   https://www.amp.org/AMP/assets/File/pressreleases/2021/AMP_MDx_Interpretation_As...
5. 345.
   AMP/assets/File/pressreleases/2024/AMP_DPYD_FINAL.pdf?pass=39

   To read the full manuscript, please visit https://doi.org/10.1016/j.jmoldx.2024.05.015. ABOUT AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 2,900+ members practice various disciplines of molecular diagnostics, including bioinformatics,

   https://www.amp.org/AMP/assets/File/pressreleases/2024/AMP_DPYD_FINAL.pdf?pass=3...
6. 346.
   AMP/assets/File/pressreleases/2021/AMP_CYP2D6_Guidelines_Press_Release061021.pdf...

   To read the full manuscript, please visit https://doi.org/10.1016/j.jmoldx.2021.05.013. ABOUT AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice various disciplines of molecular diagnostics, including bioinformatics,

   https://www.amp.org/AMP/assets/File/pressreleases/2021/AMP_CYP2D6_Guidelines_Pre...
7. 347.
   AMP/assets/File/advocacy/AMP_Comments_to_FDA_RFI_on_DPYD.pdf?pass=91

   Variants with unknown effect 1 https://pubmed.ncbi.nlm.nih.gov/39032821/ on protein func on or gene expression are not included in these recommenda ons for clinical genotyping assays. The AMP PGx Working Group recommends DPYD variants for Tier 1 include NM_000110.4:c.1905+1G>A, c.1679T>G, c.1129-5923C>G, c.557A>G, c.868A>G, c.2279C>T, and

   https://www.amp.org/AMP/assets/File/advocacy/AMP_Comments_to_FDA_RFI_on_DPYD.pdf...
8. 348.
   Trailblazers Travel Award - Association for Molecular Pathology

   Complete and submit an online application at https://ampawards.secure-platform.com/a Make sure that your director submits the required communication that your travel and registration for the annual meeting is not funded by your institution (see below). Task for the applicant's lab director/person submitting the letter of support to perform: Send an email to

   https://www.amp.org/membership/awards-grants-honors/trailblazers-travel-award/
9. 349.
   AMP/assets/File/pressreleases/2022/AMP_Pandemic_White_Paper_PR041822.pdf?pass=85

   To read the full report, please visit: https://www.amp.org/advocacy/economics-of-testing-during-a-public-health-emergency-lessons-learned-from-two-years-of-covid-19/. ABOUT AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice

   https://www.amp.org/AMP/assets/File/pressreleases/2022/AMP_Pandemic_White_Paper_...
10. 350.
    AMP/assets/File/education/case-studies/1121_42-46_AMPcase-reprint-lowres.pdf?pass=...

    a lymphoid neoplasm in COSMIC (https://cancer.sanger.ac.uk/cosmic, Genomic Mutation ID COSV66447416, accessed July 9, 2021). Discussion. The primary goal of somatic biomarker testing of tumor tissue is to detect molecular alterations for the purpose of diagnosis, prognosis, and prediction of treatment efficacy. Different testing modalities are used for

    https://www.amp.org/AMP/assets/File/education/case-studies/1121_42-46_AMPcase-re...